Multicenter Endoscopic Sleeve Gastrectomy (ESG) Trial (MERIT Trial)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 208 participants.
Also called NCT03406975
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose other
- Phase
- Not applicable
- Enrolled
- 208 participants
- Sponsor
- Registry
-
NCT03406975
-
- Other papers using this trial's data
- Effect of endoscopic sleeve gastroplasty on gastric emptying, motility and hormones: a comparative prospective study
- Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03406975. Randomized; no masking; primary purpose other. Start 2017-12-20 (actual); primary completion 2020-10-29 (actual). Results posted on 2022-10-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Multicenter Endoscopic Sleeve Gastrectomy (ESG) Trial (MERIT Trial)
- Condition
- Obesity
- Condition
- Hypertension
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Device)
- Overstitch Endoscopic Suture System
- Intervention (Behavioral)
- Lifestyle Intervention
- Lead sponsor
- Mayo Clinic
- Collaborator
- University of Texas
- Collaborator
- Johns Hopkins University
- Collaborator
- Brigham and Women's Hospital
- Collaborator
- Endeavor Health
- Collaborator
- University of Chicago
- Collaborator
- Orlando Health, Inc.
- Collaborator
- Cornell University
- Collaborator
- Avera McKennan Hospital & University Health Center
Record details
- Record id
cardio:ct-nct03406975- Content hash
bd46b974b2a6c5556df75ea474f11089182694a0e946aa2a7f9a0b04b0b3dc35